Corinne Djuric, NP
Family · Wheatfield, INNPI 1164780276
Payments from drug & device makers
Across 95 payments — averaging $87.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$7K
- Urgo Medical North America, LLC$167
- Convatec Inc.$144
- Smith+Nephew$93
- Novo Nordisk$89
- Paratek Pharmaceuticals, Inc.$67
- plus $271 from 11 others
What the payments were for
- Speaking & faculty fees$5,46066%
- Travel & lodging$5947%
- Food & beverage$2,21927%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 60 | $7,444 |
| Urgo Medical North America, LLC | 6 | $167 |
| Convatec Inc. | 6 | $144 |
| Smith+Nephew | 4 | $93 |
| Novo Nordisk | 1 | $89 |
| Paratek Pharmaceuticals, Inc. | 4 | $67 |
| Hartmann USA, Inc. | 3 | $59 |
| KCI USA, Inc. | 2 | $32 |
| Viiv Healthcare Company | 1 | $31 |
| Tactile Systems Technology Inc | 1 | $23 |
| Polynovo North America LLC | 1 | $23 |
| Bsn Medical Inc | 1 | $21 |
| Mimedx Group, Inc. | 1 | $21 |
| Solventum Corporation | 1 | $16 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Coloplast | 1 | $15 |
| Molnlycke Health Care US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURAPLY WOUND MATRIX$6,262
- Apligraf$114
- CYGNUS DUAL$114
- NOVACHOR$114
- Affinity$114
How this compares
$8,273 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 71 | $751 |
| Betamethasone Valerate | 11 | $337 |
| Ammonium Lactate | 11 | $267 |
| Ciprofloxacin Hcl | 36 | $218 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $112 |
Paid to pharmacies, not to this prescriber.
Other family in Wheatfield
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.